Back to Search Start Over

Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort.

Authors :
Debras C
Chazelas E
Sellem L
Porcher R
Druesne-Pecollo N
Esseddik Y
de Edelenyi FS
Agaësse C
De Sa A
Lutchia R
Fezeu LK
Julia C
Kesse-Guyot E
Allès B
Galan P
Hercberg S
Deschasaux-Tanguy M
Huybrechts I
Srour B
Touvier M
Source :
BMJ (Clinical research ed.) [BMJ] 2022 Sep 07; Vol. 378, pp. e071204. Date of Electronic Publication: 2022 Sep 07.
Publication Year :
2022

Abstract

Objectives: To study the associations between artificial sweeteners from all dietary sources (beverages, but also table top sweeteners, dairy products, etc), overall and by molecule (aspartame, acesulfame potassium, and sucralose), and risk of cardiovascular diseases (overall, coronary heart disease, and cerebrovascular disease).<br />Design: Population based prospective cohort study (2009-21).<br />Setting: France, primary prevention research.<br />Participants: 103 388 participants of the web based NutriNet-Santé cohort (mean age 42.2±14.4, 79.8% female, 904 206 person years). Dietary intakes and consumption of artificial sweeteners were assessed by repeated 24 h dietary records, including brand names of industrial products.<br />Main Outcomes Measures: Associations between sweeteners (coded as a continuous variable, log10 transformed) and cardiovascular disease risk, assessed by multivariable adjusted Cox hazard models.<br />Results: Total artificial sweetener intake was associated with increased risk of cardiovascular diseases (1502 events, hazard ratio 1.09, 95% confidence interval 1.01 to 1.18, P=0.03); absolute incidence rate in higher consumers (above the sex specific median) and non-consumers was 346 and 314 per 100 000 person years, respectively. Artificial sweeteners were more particularly associated with cerebrovascular disease risk (777 events, 1.18, 1.06 to 1.31, P=0.002; incidence rates 195 and 150 per 100 000 person years in higher and non-consumers, respectively). Aspartame intake was associated with increased risk of cerebrovascular events (1.17, 1.03 to 1.33, P=0.02; incidence rates 186 and 151 per 100 000 person years in higher and non-consumers, respectively), and acesulfame potassium and sucralose were associated with increased coronary heart disease risk (730 events; acesulfame potassium: 1.40, 1.06 to 1.84, P=0.02; incidence rates 167 and 164; sucralose: 1.31, 1.00 to 1.71, P=0.05; incidence rates 271 and 161).<br />Conclusions: The findings from this large scale prospective cohort study suggest a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease risk. Artificial sweeteners are present in thousands of food and beverage brands worldwide, however they remain a controversial topic and are currently being re-evaluated by the European Food Safety Authority, the World Health Organization, and other health agencies.<br />Trial Registration: ClinicalTrials.gov NCT03335644.<br />Competing Interests: Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from Ministère de la Santé, Santé Publique France, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut national de recherche pour l’agriculture, l’alimentation et l’environnement (INRAE), Conservatoire National des Arts et Métiers (CNAM) and Université Sorbonne Paris Nord, European Research Council, the French National Cancer Institute, the French Ministry of Health, and the IdEx Université Paris Cité for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.<br /> (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1756-1833
Volume :
378
Database :
MEDLINE
Journal :
BMJ (Clinical research ed.)
Publication Type :
Academic Journal
Accession number :
36638072
Full Text :
https://doi.org/10.1136/bmj-2022-071204